Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             34 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice Bueno-de-Mesquita, J.M.

22 9 p. 2021-2030
artikel
2 Alcohol drinking and colorectal cancer risk: an overall and dose–response meta-analysis of published studies Fedirko, V.

22 9 p. 1958-1972
artikel
3 A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection Wong, R.

22 9 p. 2042-2048
artikel
4 A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer Blumenschein Jr, G.R.

22 9 p. 2057-2067
artikel
5 A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors Mahadevan, D.

22 9 p. 2137-2143
artikel
6 Circulating cancer cells in division in an early breast cancer patient Serrano, M.J.

22 9 p. 2150-2151
artikel
7 Correction to: EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer
22 9 p. 2155
artikel
8 Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial Brisbois, T.D.

22 9 p. 2086-2093
artikel
9 Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study Uccella, S.

22 9 p. 2129-2136
artikel
10 Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX Aebi, S.

22 9 p. 1981-1987
artikel
11 Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: can we rely on large randomized control trials in the era of personalized medicine? Glück, S.

22 9 p. 1937-1938
artikel
12 Editorial Board
22 9 p. ii-iii
artikel
13 Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab Bates, M.

22 9 p. 2014-2020
artikel
14 Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients Marcolino, M.S.

22 9 p. 2073-2079
artikel
15 Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly Fritsch, K.

22 9 p. 2080-2085
artikel
16 Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case–control study Souza-Dantas, V.C.

22 9 p. 2094-2100
artikel
17 Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis Thiery-Vuillemin, A.

22 9 p. 2152-2154
artikel
18 Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients Font, C.

22 9 p. 2101-2106
artikel
19 Late referrals to home palliative care service affecting death at home in advanced cancer patients in Japan: a nationwide survey Fukui, S.

22 9 p. 2113-2120
artikel
20 Long-term toxic effects of adjuvant chemotherapy in breast cancer Azim Jr, H.A.

22 9 p. 1939-1947
artikel
21 Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients Maringwa, J.

22 9 p. 2107-2112
artikel
22 Novel approaches and future directions in castration-resistant prostate cancer Nabhan, C.

22 9 p. 1948-1957
artikel
23 Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy Shieh, M.P.

22 9 p. 2151-2152
artikel
24 Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer Zweifel, M.

22 9 p. 2036-2041
artikel
25 PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel±darbepoetin alfa in primary breast cancer—results at the time of surgery Untch, M.

22 9 p. 1988-1998
artikel
26 PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin–cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer—outcome on prognosis Untch, M.

22 9 p. 1999-2006
artikel
27 Response to influenza virus vaccination during chemotherapy in patients with breast cancer Meerveld-Eggink, A.

22 9 p. 2031-2035
artikel
28 Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group Stupp, R.

22 9 p. 2144-2149
artikel
29 Significance of smoking history and FDG uptake for pathological N2 staging in clinical N2-negative non-small-cell lung cancer Na, I.I.

22 9 p. 2068-2072
artikel
30 1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer Stahel, R.

22 9 p. 1973-1980
artikel
31 Table of Contents
22 9 p. iv-vi
artikel
32 Tumor–ratio–metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection—results of a single-institution study of 1343 Chinese patients Wang, W.

22 9 p. 2049-2056
artikel
33 Usefulness of a bidirectional e-learning material for explaining surgical anesthesia to cancer patients Narimatsu, H.

22 9 p. 2121-2128
artikel
34 Very high quantitative tumor HER2 content and outcome in early breast cancer Joensuu, H.

22 9 p. 2007-2013
artikel
                             34 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland